PT-141 5MG

PT-141 Peptide – Research Grade

PT-141, also known as Bremelanotide, is a synthetic peptide analog derived from melanocortin pathways and is studied in controlled laboratory environments for its relevance to central nervous system signaling, receptor interaction analysis, and neuroendocrine research models. This peptide is supplied strictly for scientific and experimental research purposes and is not intended for clinical, diagnostic, or therapeutic use.

Manufactured using advanced solid-phase peptide synthesis (SPPS), PT-141 is purified to a high degree to ensure molecular integrity, batch-to-batch consistency, and analytical reliability. Each production lot is verified through High-Performance Liquid Chromatography (HPLC) and Mass Spectrometry (MS) to confirm molecular identity, purity, and structural accuracy.

Research Characteristics

• Peptide Name: PT-141 (Bremelanotide)
• Peptide Class: Synthetic melanocortin receptor agonist peptide
• Synthesis Method: Solid-phase peptide synthesis (SPPS)
• Purity: ≥ 99% (HPLC verified)
• Form: Lyophilized powder
• Stability: Stable under recommended laboratory storage conditions

Experimental Applications

PT-141 is commonly utilized in in-vitro and pre-clinical research models investigating melanocortin receptor signaling, neurochemical pathway modulation, and peptide-receptor interaction dynamics. Its application is strictly limited to controlled laboratory studies requiring high-purity and well-characterized peptide materials.

Quality & Documentation

Each batch of PT-141 undergoes comprehensive quality control testing to ensure molecular accuracy, purity, and reproducibility prior to release. Certificates of Analysis (COA) are provided with each order to support research validation, traceability, and experimental documentation requirements.

Important Notice: This product is intended for laboratory research use only and is not for human or animal consumption. It is not intended for diagnostic, therapeutic, or clinical applications of any kind.